Evidence map›Paper›PMID 41460910›Full record

ArticlePloS one2025

A methodology for calculating the rarity of diverse proteins based on functional specificity and thermodynamic stability.

Brian J Miller

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Brian J MillerBiologic Institute, Redmond, Washington, United States of America.ORCID https://orcid.org/0000-0003-1944-1810

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A key question in protein studies is the proportion of amino acid sequences that correspond to functional proteins, often called protein rarity. This issue underlies the relationship between mutations and disease, theories on the origin of proteins, and strategies for engineering new proteins. Recent literature has detailed how to employ estimates of protein rarity to evaluate the required biasing of functional sequences in sequence space to allow for evolutionary paths to connect distinct proteins. One challenge in addressing rarity has been an imprecise definition of function and a lack of consistency in methodology. This study introduces a new methodology, referred to as PRISM, to evaluate protein rarity based on the impact of mutations on stability. PRISM offers a suite of methods that are simpler than traditional approaches while providing accurate upper-bound rarity estimates. The specific method applied is determined by the protein's function and available empirical data on how accumulating mutations affect its stability and performance. PRISM is applied to several proteins, and the accuracy of the methods is demonstrated by comparing the results to rarity estimates from previous studies. The calculated rarities align with previous research that concludes functional sequences are often exceedingly rare. The application of PRISM is outlined for research in protein engineering, protein evolution, and pathology.

Indexed as

ProteinsAlgorithmsAmino Acid SequenceMutationProtein StabilityThermodynamicsProteins

Identifiers

PMID41460910
PMCPMC12747414

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.